Literature DB >> 4473996

An abnormal platelet glycoprotein pattern in three cases of Glanzmann's thrombasthenia.

A T Nurden, J P Caen.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4473996     DOI: 10.1111/j.1365-2141.1974.tb06660.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  74 in total

Review 1.  Applications of anti-platelet monitoring in catheterization laboratory.

Authors:  D Mukherjee; D J Moliterno
Journal:  J Thromb Thrombolysis       Date:  2000-04       Impact factor: 2.300

Review 2.  Demystified...adhesion molecule deficiencies.

Authors:  D Inwald; E G Davies; N Klein
Journal:  Mol Pathol       Date:  2001-02

3.  Platelet membrane glycoproteins implicated in ristocetin-induced aggregation. Studies of the proteins on platelets from patients with Bernard-Soulier syndrome and von Willebrand's disease.

Authors:  C S Jenkins; D R Phillips; K J Clemetson; D Meyer; M J Larrieu; E F Lüscher
Journal:  J Clin Invest       Date:  1976-01       Impact factor: 14.808

4.  A new variant of Glanzmann's thrombasthenia (Strasbourg I). Platelets with functionally defective glycoprotein IIb-IIIa complexes and a glycoprotein IIIa 214Arg----214Trp mutation.

Authors:  F Lanza; A Stierlé; D Fournier; M Morales; G André; A T Nurden; J P Cazenave
Journal:  J Clin Invest       Date:  1992-06       Impact factor: 14.808

5.  A molecular defect in thrombasthenic platelets.

Authors:  L Degos; A Dautigny; J C Brouet; M Colombani; N Ardaillou; J P Caen; J Colombani
Journal:  J Clin Invest       Date:  1975-07       Impact factor: 14.808

Review 6.  The GPIIb/IIIa (integrin alphaIIbbeta3) odyssey: a technology-driven saga of a receptor with twists, turns, and even a bend.

Authors:  Barry S Coller; Sanford J Shattil
Journal:  Blood       Date:  2008-10-15       Impact factor: 22.113

7.  The international, prospective Glanzmann Thrombasthenia Registry: treatment modalities and outcomes of non-surgical bleeding episodes in patients with Glanzmann thrombasthenia.

Authors:  Giovanni Di Minno; Rainer B Zotz; Roseline d'Oiron; Niels Bindslev; Matteo Nicola Dario Di Minno; Man-Chiu Poon
Journal:  Haematologica       Date:  2015-05-22       Impact factor: 9.941

8.  Potential large animal models for gene therapy of human genetic diseases of immune and blood cell systems.

Authors:  Thomas R Bauer; Rima L Adler; Dennis D Hickstein
Journal:  ILAR J       Date:  2009

Review 9.  Platelet glycoprotein IIb/IIIa inhibitors in percutaneous coronary intervention: focus on the pharmacokinetic-pharmacodynamic relationships of eptifibatide.

Authors:  Ian C Gilchrist
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

10.  Immunoinhibition of ristocetin-induced platelet aggregation.

Authors:  R L Nachman; E A Jaffe; B B Weksler
Journal:  J Clin Invest       Date:  1977-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.